{"id":"https://openalex.org/W4282959294","doi":"https://doi.org/10.1158/1538-7445.am2022-626","title":"Abstract 626: Personalized immunotherapeutic platform with evidence of clinical activity in glioblastoma (IGV-001) protects mice against other lethal solid tumor challenges","display_name":"Abstract 626: Personalized immunotherapeutic platform with evidence of clinical activity in glioblastoma (IGV-001) protects mice against other lethal solid tumor challenges","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282959294","doi":"https://doi.org/10.1158/1538-7445.am2022-626"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-626","doi":"https://doi.org/10.1158/1538-7445.am2022-626","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-626","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5013268190","display_name":"Jenny Zilberberg","orcid":"https://orcid.org/0000-0002-4139-2616","observed_orcids":["https://orcid.org/0000-0002-4139-2616"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jenny Zilberberg","raw_affiliation_strings":["1Imvax, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Imvax, Philadelphia, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000385564","display_name":"Amelia Zellander","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amelia Zellander","raw_affiliation_strings":["1Imvax, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Imvax, Philadelphia, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Christopher Uhl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher Uhl","raw_affiliation_strings":["1Imvax, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Imvax, Philadelphia, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014591774","display_name":"Christopher N. Cultrara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christopher Cultrara","raw_affiliation_strings":["1Imvax, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Imvax, Philadelphia, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066302054","display_name":"Kenneth W. Kirby","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenneth kirby","raw_affiliation_strings":["1Imvax, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Imvax, Philadelphia, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066262987","display_name":"Essam Elazaq","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Essam Elazaq","raw_affiliation_strings":["1Imvax, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Imvax, Philadelphia, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030653008","display_name":"Charles Scott","orcid":"https://orcid.org/0000-0003-0410-9401","observed_orcids":["https://orcid.org/0000-0003-0410-9401"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles B. Scott","raw_affiliation_strings":["2CBS Squared Inc, Philadelphia, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2CBS Squared Inc, Philadelphia, PA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067700684","display_name":"David Andrews","orcid":"https://orcid.org/0000-0001-6074-080X","observed_orcids":["https://orcid.org/0000-0001-6074-080X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David W. Andrews","raw_affiliation_strings":["1Imvax, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Imvax, Philadelphia, PA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5019377810","display_name":"Mark Adrian Exley","orcid":"https://orcid.org/0000-0002-5088-1032","observed_orcids":["https://orcid.org/0000-0002-5088-1032"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mark Exley","raw_affiliation_strings":["1Imvax, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Imvax, Philadelphia, PA;","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"626","last_page":"626"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.4918999969959259,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.4918999969959259,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10129","display_name":"Glioma Diagnosis and Treatment","score":0.35989999771118164,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.11659999936819077,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glioblastoma","display_name":"glioblastoma","score":0.7160000205039978},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6700000166893005},{"id":"https://openalex.org/keywords/insulin-like-growth-factor-type-1-receptor","display_name":"insulin-like growth factor type 1 receptor","score":0.7900000214576721},{"id":"https://openalex.org/keywords/antisense-oligonucleotides","display_name":"antisense oligonucleotides","score":0.949999988079071},{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.5960000157356262},{"id":"https://openalex.org/keywords/hepatocellular-carcinoma","display_name":"hepatocellular carcinoma","score":0.9980000257492065},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8370000123977661},{"id":"https://openalex.org/keywords/mhc-class-i","display_name":"MHC class I","score":0.5590000152587891},{"id":"https://openalex.org/keywords/tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating lymphocytes","score":0.515999972820282},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.3109999895095825}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7757325768470764},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.5478132367134094},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.5202292799949646},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5151704549789429},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4885490834712982},{"id":"https://openalex.org/C2776194525","wikidata":"https://www.wikidata.org/wiki/Q282142","display_name":"Glioblastoma","level":2,"score":0.4772084355354309},{"id":"https://openalex.org/C161997846","wikidata":"https://www.wikidata.org/wiki/Q4915066","display_name":"Bioluminescence imaging","level":5,"score":0.46225351095199585},{"id":"https://openalex.org/C2779256057","wikidata":"https://www.wikidata.org/wiki/Q16909647","display_name":"Tumor progression","level":3,"score":0.455456405878067},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37658506631851196},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3765803873538971},{"id":"https://openalex.org/C111335760","wikidata":"https://www.wikidata.org/wiki/Q95385166","display_name":"Luciferase","level":4,"score":0.22848770022392273},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.15337520837783813},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.15079575777053833},{"id":"https://openalex.org/C54009773","wikidata":"https://www.wikidata.org/wiki/Q1429031","display_name":"Transfection","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-626","doi":"https://doi.org/10.1158/1538-7445.am2022-626","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-626","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4308394851","https://openalex.org/W3212601170","https://openalex.org/W3179127036","https://openalex.org/W4385622562","https://openalex.org/W4404237094","https://openalex.org/W4404237640","https://openalex.org/W4389432268","https://openalex.org/W3125945798","https://openalex.org/W4308407496","https://openalex.org/W4404064105"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"IGV-001":[2],"is":[3,348],"a":[4,45,230,351],"novel":[5,336],"immunotherapy":[6],"that":[7,33,346],"combines":[8],"irradiated":[9],"patient-derived":[10],"glioblastoma":[11,37,132,420],"tumor":[12,111,152,236,270,282,428],"cells":[13,112],"and":[14,99,115,125,151,161,240,261,281,294,385],"an":[15],"antisense":[16],"oligonucleotide":[17],"against":[18,424],"insulin-like":[19],"growth":[20],"factor":[21],"type":[22],"1":[23],"receptor":[24],"(IMV-001)":[25],"in":[26,57,72,120,181,210,250,264,284,291,302,316,339,356,419],"biodiffusion":[27],"chambers":[28],"(BDC).":[29],"We":[30,62,87],"recently":[31],"reported":[32],"IGV-001-treated":[34],"newly":[35],"diagnosed":[36],"patients":[38,60],"with":[39,54,67,306,350,414],"methylated":[40],"O6-methylguanine-DNA":[41],"methyl-transferase":[42],"promoter":[43],"had":[44,227],"median":[46],"progression":[47],"free":[48],"survival":[49,150,309],"of":[50,80,122,167,179,192,223,235,278,334,358,380,416,433],"38.4":[51],"months":[52,56],"compared":[53,175,253],"8.3":[55],"historical":[58],"standard-of-care-treated":[59],"(P=0.0008).":[61],"have":[63],"now":[64],"found":[65,275],"activity":[66,333,418],"the":[68,77,93,182,188,211,224,317,331,370,434],"equivalent":[69],"murine":[70,90],"approach":[71,312],"multiple":[73,340],"cancer":[74,98],"models,":[75],"highlighting":[76],"transformative":[78],"potential":[79],"this":[81,311,335],"immunotherapeutic":[82,337,412],"platform":[83,338,413],"beyond":[84,214,342],"glioblastoma.":[85,343],"Methodology:":[86],"utilized":[88],"several":[89],"models":[91,139],"including":[92],"ID8-luciferase":[94],"(-Luc)":[95],"intraperitoneal":[96],"ovarian":[97],"Hepa1-6-Luc":[100],"hepatocellular":[101],"carcinoma":[102],"orthotopic":[103,319],"model.":[104,321],"BDC":[105],"containing":[106],"saline":[107,183,212],"or":[108],"1x106":[109],"IMV-001-treated":[110],"(hereon":[113],"IOV-001":[114],"IHV-001,":[116],"respectively)":[117],"were":[118,147,163,170,195,207,274],"implanted":[119],"flanks":[121],"C57BL/6":[123],"mice":[124,169,180,194,252,304,423],"explanted":[126],"48":[127],"h":[128],"later,":[129],"as":[130,154],"per":[131],"clinical":[133,417],"protocol.":[134],"Tumor":[135],"challenge":[136,200,259],"for":[137,149,437],"all":[138],"was":[140,247,299,313],"conducted":[141],"28d":[142,215],"after":[143,269],"chamber":[144],"implantation.":[145],"Mice":[146],"monitored":[148],"growth,":[153],"determined":[155],"by":[156,197],"bioluminescence":[157],"intensity.":[158],"Cytokine":[159],"assays":[160],"immunophenotyping":[162],"conducted.":[164],"Results:":[165],"60%":[166],"IOV-001-treated":[168,251,285],"alive":[171,196],"58d":[172],"post-tumor":[173,199,258],"challenge,":[174],"to":[176,254,368],"only":[177],"19%":[178],"group":[184,213],"(MST=37d,":[185],"p=0.004).":[186],"In":[187,204],"Hepa1-6":[189],"model,":[190],"50%":[191],"IHV-001-treated":[193],"100d":[198],"(MST":[201,216],"=":[202,217,220],"60.5d).":[203],"comparison,":[205],"there":[206],"no":[208],"survivors":[209,226],"18d;":[218],"p":[219],"0.004).":[221],"Most":[222],"long-term":[225],"undetectable":[228],"tumor;":[229],"fraction":[231],"showed":[232],"some":[233],"level":[234],"burden":[237,283],"which":[238],"rose":[239],"fell,":[241],"demonstrating":[242],"immune":[243],"control.":[244],"Circulating":[245],"IFN\u03b3":[246],"significantly":[248,300],"higher":[249,263],"controls":[255],"on":[256],"1d":[257],"(p<0.001)":[260],"trended":[262],"those":[265],"receiving":[266],"IHV-001":[267],"14d":[268],"challenge.":[271],"Positive":[272],"correlations":[273],"between":[276],"percentages":[277],"CD8+PD1+and":[279],"CD4+TIM3+,":[280],"mice.":[286],"On":[287],"14d,":[288],"PD1+":[289],"expression":[290],"both":[292],"CD4+":[293],"CD8+":[295],"T":[296,362,381],"cell":[297,382],"subsets":[298],"lower":[301],"surviving":[303],"treated":[305],"IHV-001.":[307],"Improved":[308],"using":[310,377],"also":[314],"observed":[315],"Pan02":[318],"pancreatic":[320],"Latest":[322],"data":[323,329],"will":[324],"be":[325],"presented.":[326],"Conclusions:":[327],"These":[328],"support":[330],"antitumor":[332,360],"cancers":[341],"Results":[344],"suggest":[345],"efficacy":[347],"associated":[349],"systemic":[352],"immunological":[353],"response,":[354],"resulting":[355],"generation":[357],"Th1":[359],"cytotoxic":[361],"cells.":[363],"Future":[364],"studies":[365],"are":[366],"seeking":[367],"resolve":[369],"factors":[371],"triggering":[372],"good":[373],"v.":[374],"poor":[375],"responses":[376],"phenotypic":[378],"evaluation":[379],"activation/exhaustion":[383],"markers":[384],"Th1/Th2":[386],"cytokine":[387],"production.":[388],"Citation":[389],"Format:":[390],"Jenny":[391],"Zilberberg,":[392],"Amelia":[393],"Zellander,":[394],"Christopher":[395,397],"Uhl,":[396],"Cultrara,":[398],"Kenneth":[399],"kirby,":[400],"Essam":[401],"Elazaq,":[402],"Charles":[403],"B.":[404],"Scott,":[405],"David":[406],"W.":[407],"Andrews,":[408],"Mark":[409],"Exley.":[410],"Personalized":[411],"evidence":[415],"(IGV-001)":[421],"protects":[422],"other":[425],"lethal":[426],"solid":[427],"challenges":[429],"[abstract].":[430],"In:":[431],"Proceedings":[432],"American":[435],"Association":[436],"Cancer":[438,449],"Research":[439],"Annual":[440],"Meeting":[441],"2022;":[442],"2022":[443],"Apr":[444],"8-13.":[445],"Philadelphia":[446],"(PA):":[447],"AACR;":[448],"Res":[450],"2022;82(12_Suppl):Abstract":[451],"nr":[452],"626.":[453]},"counts_by_year":[{"year":2023,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-06-17T00:00:00"}